J. N. Ingle

3.3k total citations · 1 hit paper
43 papers, 2.4k citations indexed

About

J. N. Ingle is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, J. N. Ingle has authored 43 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Genetics and 14 papers in Cancer Research. Recurrent topics in J. N. Ingle's work include Estrogen and related hormone effects (17 papers), Cancer Treatment and Pharmacology (11 papers) and Breast Cancer Treatment Studies (11 papers). J. N. Ingle is often cited by papers focused on Estrogen and related hormone effects (17 papers), Cancer Treatment and Pharmacology (11 papers) and Breast Cancer Treatment Studies (11 papers). J. N. Ingle collaborates with scholars based in United States, Canada and Switzerland. J. N. Ingle's co-authors include Antonio G. Nascimento, Camilo Adem, Christopher A. Reynolds, Vera J. Suman, Mitch Dowsett, Lester E. Wold, Daniel Rayson, Alex A. Adjei, L. E. Shepherd and N E Davidson and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

J. N. Ingle

41 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

2009 581 citations Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. N. Ingle United States	18	1.4k	1.2k	678	501	491	43	2.4k
Reena S. Cecchini United States	20	1.8k 1.2×	959 0.8×	1.1k 1.6×	422 0.8×	370 0.8×	49	2.9k
Giuseppe D’Aiuto Italy	28	1.4k 1.0×	1.2k 1.1×	533 0.8×	311 0.6×	334 0.7×	90	2.8k
D C Tormey United States	32	2.1k 1.5×	1.1k 1.0×	644 0.9×	718 1.4×	578 1.2×	55	3.6k
J A McKinna United Kingdom	26	913 0.6×	959 0.8×	875 1.3×	281 0.6×	704 1.4×	51	2.5k
K Holli Finland	28	1.8k 1.3×	1.3k 1.2×	772 1.1×	380 0.8×	468 1.0×	47	3.0k
J.-C. Gazet United Kingdom	28	1.8k 1.3×	1.2k 1.0×	685 1.0×	502 1.0×	590 1.2×	59	3.2k
A. Rubagotti Italy	32	1.6k 1.1×	1.2k 1.1×	1.3k 1.9×	934 1.9×	479 1.0×	131	3.7k
I E Smith United Kingdom	23	1.8k 1.3×	1.5k 1.3×	1.1k 1.6×	657 1.3×	457 0.9×	59	3.5k
Rossella Lauria Italy	18	1.2k 0.9×	683 0.6×	352 0.5×	279 0.6×	239 0.5×	61	1.9k
Yasuo Hozumi Japan	23	964 0.7×	704 0.6×	549 0.8×	522 1.0×	247 0.5×	84	1.9k

Countries citing papers authored by J. N. Ingle

Since Specialization

Citations

This map shows the geographic impact of J. N. Ingle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. N. Ingle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. N. Ingle more than expected).

Fields of papers citing papers by J. N. Ingle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. N. Ingle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. N. Ingle. The network helps show where J. N. Ingle may publish in the future.

Co-authorship network of co-authors of J. N. Ingle

This figure shows the co-authorship network connecting the top 25 collaborators of J. N. Ingle. A scholar is included among the top collaborators of J. N. Ingle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. N. Ingle. J. N. Ingle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iankov, Ianko, Cheyne Kurokawa, Antonino B. D’Assoro, et al.. (2015). Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy. Cancer Gene Therapy. 22(9). 438–444. 18 indexed citations

Solin, Lawrence J., Robert P. Gray, Frederick L. Baehner, et al.. (2013). A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast. JNCI Journal of the National Cancer Institute. 105(10). 701–710. 335 indexed citations

Goss, Paul E., J. N. Ingle, Silvana Martino, et al.. (2012). Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole. Annals of Oncology. 24(2). 355–361. 60 indexed citations

Gucalp, Ayca, SM Tolaney, SJ Isakoff, et al.. (2011). TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR- metastatic breast cancer (MBC).. Journal of Clinical Oncology. 29(15_suppl). TPS122–TPS122. 4 indexed citations

Bardia, Aditya, Lori J. Sokoll, J. N. Ingle, et al.. (2010). Circulating tumor cell (CTC) and CA2729 as predictors of outcome in patients with metastatic breast cancer (MBC) in the prospective TBCRC 005 biomarker study.. Journal of Clinical Oncology. 28(15_suppl). 1001–1001. 2 indexed citations

Dowsett, Mitch, Jack Cuzick, J. N. Ingle, et al.. (2009). Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen. Journal of Clinical Oncology. 28(3). 509–518. 581 indexed citations breakdown →

Shepherd, L. E., et al.. (2008). Competing Causes of Death From a Randomized Trial of Extended Adjuvant Endocrine Therapy for Breast Cancer. JNCI Journal of the National Cancer Institute. 100(4). 252–260. 135 indexed citations

Ingle, J. N., Dongsheng Tu, Joseph L. Pater, et al.. (2008). Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17. Annals of Oncology. 19(5). 877–882. 46 indexed citations

Hillner, Bruce E., J. N. Ingle, Rowan T. Chlebowski, & Richard L. Theriault. (2004). American society of clinical oncology 2003 update on the role of biophosphonates and bone health issues in women with breast cancer. Breast Diseases A Year Book Quarterly. 15(2). 121–122. 103 indexed citations

10.

Goss, Paul E., J. N. Ingle, Silvana Martino, et al.. (2004). Updated analysis of the NCIC CTG MA.17 randomized placebo (P) controlled trial of letrozole (L) after five years of tamoxifen in postmenopausal women with early stage breast cancer. Journal of Clinical Oncology. 22(14_suppl). 847–847. 63 indexed citations

11.

Roche, Patrick C., VJ Suman, Robert B. Jenkins, et al.. (2002). Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831. JNCI Journal of the National Cancer Institute. 94(11). 855–857. 313 indexed citations

12.

Roche, Patrick C., et al.. (2001). Utilization of gene expression profiling to identify markers of disease recurrence in node-negative breast cancer. Breast Cancer Research and Treatment. 69(3). 1 indexed citations

13.

Rayson, Daniel, Alex A. Adjei, Vera J. Suman, Lester E. Wold, & J. N. Ingle. (1999). Metaplastic breast cancer: Prognosis and response to systemic therapy. Annals of Oncology. 10(4). 413–419. 176 indexed citations

14.

Tankersley, William G., et al.. (1999). 180. A Practical and Affordable Worker Exposure Surveillance System. 180–180.

15.

Watkins, Janice P., et al.. (1995). Uranium Dust Exposure and Lung Cancer Risk in Four Uranium Processing Operations. Epidemiology. 6(4). 370–375. 36 indexed citations

16.

Creagan, Edward T., J. N. Ingle, Allan J. Schutt, & Daniel J. Schaid. (1989). A Prospective, Randomized Controlled Trial of Megestrol Acetate Among High-Risk Patients with Resected Malignant Melanoma. American Journal of Clinical Oncology. 12(2). 152–155. 25 indexed citations

17.

Long, Harry J., Daniel J. Schaid, Allan J. Schutt, et al.. (1988). Phase II Evaluation of Menogaril in Women with Metastatic Breast Cancer after Failure of First-Line Chemotherapy. American Journal of Clinical Oncology. 11(5). 524–527. 7 indexed citations

18.

Martínez, Alejandra, David L. Ahmann, William D. Payne, et al.. (1984). An interim analysis of the randomized surgical adjuvant trial for patients with unfavorable breast cancer. International Journal of Radiation Oncology*Biology*Physics. 10. 106–106. 18 indexed citations

19.

Ingle, J. N., S. Fred Brunk, & James E. Krook. (1982). Randomized trial of adriamycin (ADR) versus adriamycin + dibromodulcitol (DBD) as second line chemotherapy in women with advanced breast cancer. 23. 2 indexed citations

20.

Ingle, J. N., David L. Ahmann, Judith R. OʼFallon, et al.. (1980). Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer.. PubMed. 63(11-12). 1701–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact